Recently in Cervical Cancer Category

FDA(NewsTarget) For the last several years, HPV vaccines have been marketed to the public and mandated in compulsory injections for young girls in several states based on the idea that they prevent cervical cancer. Now, NewsTarget has obtained documents from the FDA and other sources (see below) which reveal that the FDA has been well aware for several years that Human Papilloma Virus (HPV) has no direct link to cervical cancer.

NewsTarget has also learned that HPV vaccines have been proven to be flatly worthless in clearing the HPV virus from women who have already been exposed to HPV (which includes most sexually active women), calling into question the scientific justification of mandatory "vaccinate everyone" policies.

Furthermore, this story reveals evidence that the vaccine currently being administered for HPV -- Gardasil -- may increase the risk of precancerous cervical lesions by an alarming 44.6 percent in some women. The vaccine, it turns out, may be far more dangerous to the health of women than doing nothing at all.

Young women at threat of cervical cancer


smear test Thousands of young women could be at risk of life-theatening cervical cancer after being excluded from the NHS screening programme, say doctors.

Regular smear tests are no longer offered to women under 25 and experts say at least 3,000 women will develop abnormalities that could result in cancer if left untreated.

A change of policy in 2004 stopped women aged 20 to 24 years from getting screening tests on the grounds it could do 'more harm than good'.

Merck lobbies states over cancer vaccine


gardasilMerck & Co. is helping bankroll efforts to pass state laws requiring girls as young as 11 or 12 to receive the drugmaker's new vaccine against the sexually transmitted cervical-cancer virus.

Some conservatives and parents'-rights groups say such a requirement would encourage premarital sex and interfere with the way they raise their children, and they say Merck's push for such laws is underhanded. But the company said its lobbying efforts have been above-board.

With at least 18 states debating whether to require Merck's Gardasil vaccine for schoolgirls, Merck has funneled money through Women in Government, an advocacy group made up of female state legislators around the country.

A top official from Merck's vaccine division sits on Women in Government's business council, and many of the bills around the country have been introduced by members of Women in Government.

GSKStudy to compare immunogencity of GSK’s cervical cancer candidate vaccine, CERVARIX® , to Merck’s Gardasil® 

Issued — Thursday 18 January 2007, London, UK & Philadelphia, PA - GlaxoSmithKline announced today the initiation of the first study of its kind designed to compare the immunogenicity of its cervical cancer candidate vaccine, CERVARIX®, versus Gardasil®. The primary objective of the head-to-head trial is to compare the immune responses to HPV types 16 and 18 in U.S. women 18 to 26-years-old. Secondary objectives include evaluating the immune responses to HPV 16 and 18 in women 27 to 35-years-old and 36 to 45-years-old. In addition, the study will compare immune responses to other cancer-causing HPV types. Initial study results are anticipated 12 months after studyenrollmentis completed, and extended follow up will continue for another 17 months.

Sex and Pregnancy in Cancer SurvivorsChris Knutson, ANP, MN

"Survivorship medicine" is becoming a more frequent challenge for practitioners of all specialties. Women cancer survivors who make their way back into "routine" care following cancer treatment have questions and concerns that could hardly be considered routine. Some will ultimately be cured. Some will deal with cancer's chronicity. All of them find their lives forever changed by cancer.

Michael Krychman, MD, Co-Director of the Sexual Medicine Program at Memorial Sloan-Kettering Cancer Center, New York, recently spoke of the reproductive and sexual concerns of women with cancer. He reminds his patients that "you may survive this illness but your life will never, ever be the same." Helping patients come to grips with that concept and making accommodations to enhance or preserve sexual functioning and fertility are increasingly frequent and critical components of cancer care.

Breast cancer may be sexually transmitted


HPV virusBreast cancer could be sexually transmitted, says a researcher who has found the same virus that causes cervical cancer in breast cancer tumours from Australian women.

Emeritus Professor James Lawson of the University of New South Wales and colleagues have found the same form of the human papillomavirus (HPV) associated with cervical cancer in almost half the breast tumour samples they tested.

It's the first study of its kind in Australia, although international studies have also found cervical cancer-related HPV in breast cancer cells.

AMA warns against cervical cancer complacency


gardasil The Australian Medical Association (AMA) has welcomed a decision to put the cervical cancer vaccine Gardasil on the national immunisation program, but says screening for older women must be stepped up.

The Federal Government has given the go ahead for the $436 million immunisation program which will be carried out through schools from April next year.

It will also be available through GPs for the next two years for women aged 18 to 26.

The AMA's national president, Doctor Mukesh Haikerwal, says the move will reduce cervical cancer rates into the future, but it does not reduce the need for normal screening.

Cervical cancer vaccine in immunisation plan sought


cervical cancerDUBAI - A controversial cervical cancer vaccine, which was recently approved in the UAE, may be included in the immunisation programmes of the various health authorities, says a senior official at the pharmaceutical company.

The vaccine protects against certain types of the human papilloma virus (HPV), a sexually transmitted infection that causes cervical cancer in women.

About half a million women worldwide die of cervical cancer each year. It is controversial as some have argued it may encourage promiscuity.

Cuba patents new treatment for cervical cancer

cervical cancerHAVANA (AFP) - Cuba has patented a new treatment for cervical cancer with less harmful side effects than conventional therapies, a group of researchers said.

The treatment involves a peptide that inhibits and kills the CK2 enzime found in high concentration in malignant tumors, said Silvio Perera, who leads the Molecular Oncology project of Cuba's Biological and Genetical Engineering Center.

"The idea behind this new product is to develop it for use in related tumors of the anus and genital area and, in future, for lung cancer," Perera told 600 researchers from 40 countries gathered at the 2006 Havana Biotechnology Congress.

Survey: Most Women Don't Know Virus Causes Cervical Cancer


hpv virus Americans are in the dark about a virus linked to cervical cancer that can kill them, two new studies suggest.

A vaccine exists to protect against types of the virus, called human papillomaviruses (HPV).

But when the vaccine is presented under the umbrella of sexually-transmitted-disease protection, women are less likely to get inoculated.

Every year in the United States, about 6.2 million people get HPV.

Anyone who has ever had genital contact with another person can get HPV. Both men and women can get it — and pass it on to their sex partners — without even realizing it.

The studies were presented Sunday at the American Association for Cancer Research's Frontiers in Cancer Prevention Research meeting in Boston.

About this Archive

This page is a archive of recent entries in the Cervical Cancer category.

Breast Cancer is the previous category.

Colon/Bowel Cancer is the next category.

Find recent content on the main index or look in the archives to find all content.